Compositions and methods for treating cancer with anti-CD22 immunotherapy

• 收藏
• 分享

专利权人:

The U.S.A., as represented by the Secretary, Department of Health and Human Services;Lentigen Technology, Inc.

发明人:

ORENTAS, Rimas J.,SCHNEIDER, Dina,DROPULIC, Boro,DIMITROV, Dimiter S.,ZHU, Zhongyu

申请号：

AU2018352245

公开号：

AU2018352245A1

申请日:

2018.10.16

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Chimeric antigen receptors (CARs) containing CD22 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the CARsare also disclosed. Methods of treating or preventing cancer in a subject, and methods of making CAR T cells are also disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/